Metabolic substrate utilization in stress-induced immune cells.

Catecholamines Glycolysis Immunometabolism Oxidative phosphorylation Pentose phosphate pathway Reactive oxygen species Tricarboxylic acid cycle

Journal

Intensive care medicine experimental
ISSN: 2197-425X
Titre abrégé: Intensive Care Med Exp
Pays: Germany
ID NLM: 101645149

Informations de publication

Date de publication:
18 Dec 2020
Historique:
received: 07 06 2020
accepted: 11 06 2020
entrez: 18 12 2020
pubmed: 19 12 2020
medline: 19 12 2020
Statut: epublish

Résumé

Immune cell activation leads to the acquisition of new functions, such as proliferation, chemotaxis, and cytokine production. These functional changes require continuous metabolic adaption in order to sustain ATP homeostasis for sufficient host defense. The bioenergetic demands are usually met by the interconnected metabolic pathways glycolysis, TCA cycle, and oxidative phosphorylation. Apart from glucose, other sources, such as fatty acids and glutamine, are able to fuel the TCA cycle.Rising evidence has shown that cellular metabolism has a direct effect on the regulation of immune cell functions. Thus, quiescent immune cells maintain a basal metabolic state, which shifts to an accelerated metabolic level upon immune cell activation in order to promote key effector functions.This review article summarizes distinct metabolic signatures of key immune cell subsets from quiescence to activation and demonstrates a methodical concept of how to assess cellular metabolic pathways. It further discusses why metabolic functions are of rising interest for translational research and how they can be affected by the underlying pathophysiological condition and/or therapeutic interventions.

Identifiants

pubmed: 33336295
doi: 10.1186/s40635-020-00316-0
pii: 10.1186/s40635-020-00316-0
pmc: PMC7746792
doi:

Types de publication

Journal Article Review

Langues

eng

Pagination

28

Subventions

Organisme : DFG
ID : CRC 1149
Organisme : DFG
ID : GRK 2203
Organisme : DFG
ID : GRK 2203
Organisme : DFG
ID : GRK 2203
Organisme : DFG
ID : GRK 2203
Organisme : DFG
ID : GRK 2203
Organisme : China Scholarship Council
ID : 201806160164

Références

Metab Eng. 2013 Jan;15:34-47
pubmed: 23111062
J Immunol. 2010 Jul 1;185(1):605-14
pubmed: 20498354
Nat Immunol. 2013 Oct;14(10):1064-72
pubmed: 23955661
Crit Care. 2006 Feb;10(1):208
pubmed: 16469133
J Biol Chem. 2017 Oct 13;292(41):16804-16809
pubmed: 28842493
Clin Sci (Lond). 2015 Sep;129(6):489-504
pubmed: 25951298
Science. 2016 Apr 22;352(6284):aaf1098
pubmed: 27102489
Blood. 2010 Jun 10;115(23):4742-9
pubmed: 20351312
Immunology. 2015 Jun;145(2):213-24
pubmed: 25545227
Semin Immunol. 2016 Oct;28(5):514-524
pubmed: 27825556
Blood. 2008 Aug 15;112(4):935-45
pubmed: 18684880
Redox Biol. 2014 Jan 10;2:206-10
pubmed: 24494194
Front Immunol. 2014 Sep 02;5:420
pubmed: 25228902
Front Immunol. 2012 Aug 06;3:228
pubmed: 22888331
Nature. 2007 Oct 11;449(7163):721-5
pubmed: 17914358
J Exp Med. 1984 Dec 1;160(6):1656-71
pubmed: 6096475
J Nutr Biochem. 1999 Jun;10(6):316-24
pubmed: 15539305
Pediatr Crit Care Med. 2015 Jan;16(1):e4-e12
pubmed: 25251517
Crit Care Med. 2007 Dec;35(12):2702-8
pubmed: 18074472
PLoS One. 2017 Sep 18;12(9):e0185085
pubmed: 28922380
J Biol Chem. 1959 Jun;234(6):1355-62
pubmed: 13654378
Eur J Immunol. 2009 Dec;39(12):3511-9
pubmed: 19768695
Annu Rev Immunol. 2008;26:421-52
pubmed: 18303997
FASEB J. 2004 Aug;18(11):1303-5
pubmed: 15180958
F1000Prime Rep. 2014 Mar 03;6:13
pubmed: 24669294
Immunity. 2012 Jan 27;36(1):68-78
pubmed: 22206904
Sci Rep. 2015 May 28;5:10229
pubmed: 26018291
Eur J Clin Invest. 2007 Apr;37(4):282-90
pubmed: 17373964
J Biol Chem. 2015 Sep 4;290(36):22174-83
pubmed: 26198639
J Biol Chem. 2016 Jan 1;291(1):1-10
pubmed: 26534957
Anesthesiology. 2016 Jul;125(1):237-49
pubmed: 27183167
J Immunol. 2010 Feb 1;184(3):1200-9
pubmed: 20026743
Blood. 2012 Oct 11;120(15):3118-25
pubmed: 22919032
Curr Opin Biotechnol. 2015 Aug;34:189-201
pubmed: 25731751
iScience. 2018 Jul 27;5:99-109
pubmed: 30240649
Biochem J. 1986 Oct 1;239(1):121-5
pubmed: 3800971
Immunity. 2013 Apr 18;38(4):633-43
pubmed: 23601682
Nat Commun. 2019 May 3;10(1):2042
pubmed: 31053703
Cell Metab. 2017 Jun 6;25(6):1282-1293.e7
pubmed: 28416194
Metab Eng. 2007 Jan;9(1):68-86
pubmed: 17088092
J Immunol. 2007 Oct 15;179(8):4953-7
pubmed: 17911579
J Leukoc Biol. 2019 Feb;105(2):211-213
pubmed: 30618209
Immunity. 2017 May 16;46(5):743-755
pubmed: 28514675
Front Cell Infect Microbiol. 2017 Aug 25;7:373
pubmed: 28890882
Immunity. 2017 Sep 19;47(3):466-480.e5
pubmed: 28916263
Am J Respir Crit Care Med. 2016 Sep 1;194(5):550-8
pubmed: 27398737
Naunyn Schmiedebergs Arch Pharmacol. 1994 Mar;349(3):295-300
pubmed: 7911559
J Exp Med. 2011 Jul 4;208(7):1367-76
pubmed: 21708926
Cell Metab. 2016 Dec 13;24(6):807-819
pubmed: 27866838
Nat Immunol. 2016 Dec;17(12):1459-1466
pubmed: 27695003
J Leukoc Biol. 2019 Jul;106(1):11-25
pubmed: 31169935
Cell Metab. 2006 Jul;4(1):13-24
pubmed: 16814729
Science. 2009 May 22;324(5930):1029-33
pubmed: 19460998
Immunol Rev. 2000 Feb;173:89-97
pubmed: 10719670
Trends Mol Med. 2019 Jan;25(1):33-46
pubmed: 30442494
Annu Rev Biochem. 2016 Jun 2;85:765-92
pubmed: 27050287
Am J Physiol. 1997 Jun;272(6 Pt 1):C2049-62
pubmed: 9227434
Biosci Rep. 2001 Oct;21(5):627-35
pubmed: 12168770
Methods Mol Biol. 2012;844:115-24
pubmed: 22262438
Science. 2014 Sep 26;345(6204):1250684
pubmed: 25258083
J Cell Mol Med. 2007 Jan-Feb;11(1):156-70
pubmed: 17367510
Annu Rev Pathol. 2011;6:275-97
pubmed: 21034223
J Clin Invest. 2016 Oct 3;126(10):3699-3707
pubmed: 27571407
Biol Chem. 2012 Dec;393(12):1485-1512
pubmed: 23092819
Biochem J. 1989 Jul 1;261(1):211-8
pubmed: 2775207
J Neurosurg. 2019 Dec 20;134(1):223-234
pubmed: 31860806
Science. 2013 Oct 11;342(6155):1242454
pubmed: 24115444
J Leukoc Biol. 2019 Jul;106(1):7-9
pubmed: 31087702
J Clin Invest. 1977 Dec;60(6):1266-79
pubmed: 199619
J Immunol. 2011 Mar 15;186(6):3299-303
pubmed: 21317389
Cell. 2013 Jun 6;153(6):1239-51
pubmed: 23746840
Biochem J. 1973 Jul;134(3):707-16
pubmed: 4749271
Mediators Inflamm. 2017;2017:9029327
pubmed: 29386753
J Immunol. 2003 Feb 15;170(4):1964-72
pubmed: 12574365
Nat Immunol. 2016 Apr;17(4):406-13
pubmed: 26950237
Cell. 2003 Mar 7;112(5):645-57
pubmed: 12628185
Braz J Med Biol Res. 1999 Jan;32(1):15-21
pubmed: 10347763
Immunology. 2019 Oct;158(2):104-120
pubmed: 31318442
Annu Rev Immunol. 2013;31:259-83
pubmed: 23298210
J Exp Med. 2015 Aug 24;212(9):1345-60
pubmed: 26261266
J Leukoc Biol. 2019 Feb;105(2):215-228
pubmed: 30633362
Acta Haematol. 2004;111(1-2):56-66
pubmed: 14646345
Int J Hematol. 2006 Oct;84(3):199-204
pubmed: 17050191
Front Immunol. 2018 Jun 21;9:1404
pubmed: 30013547
J Biol Chem. 1994 Sep 23;269(38):23757-63
pubmed: 8089148
Eur J Immunol. 2008 Sep;38(9):2412-8
pubmed: 18792019
Curr Opin Immunol. 2010 Jun;22(3):314-20
pubmed: 20189791
Semin Hematol. 1968 Apr;5(2):156-65
pubmed: 5654923
Shock. 2017 Oct;48(4):390-400
pubmed: 28915214
Blood. 2006 Jun 1;107(11):4458-65
pubmed: 16449529
Science. 1956 Feb 24;123(3191):309-14
pubmed: 13298683

Auteurs

Xiaomin Zhang (X)

Institut für Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätsklinikum Ulm, Helmholzstraße 8/1, 89081, Ulm, Germany.

Fabian Zink (F)

Institut für Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätsklinikum Ulm, Helmholzstraße 8/1, 89081, Ulm, Germany. fabian.zink@uni-ulm.de.

Felix Hezel (F)

Institut für Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätsklinikum Ulm, Helmholzstraße 8/1, 89081, Ulm, Germany.

Josef Vogt (J)

Institut für Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätsklinikum Ulm, Helmholzstraße 8/1, 89081, Ulm, Germany.

Ulrich Wachter (U)

Institut für Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätsklinikum Ulm, Helmholzstraße 8/1, 89081, Ulm, Germany.

Martin Wepler (M)

Institut für Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätsklinikum Ulm, Helmholzstraße 8/1, 89081, Ulm, Germany.
Klinik für Anästhesiologie, Universitätsklinikum Ulm, Ulm, Germany.

Maurizio Loconte (M)

Anesthesia and Intensive Care, San Martino Policlinico Hospital, IRCCS for Oncolocy and Neuroscience, Genoa, Italy.

Christine Kranz (C)

Institut für Analytische und Bioanalytische Chemie, Universität Ulm, Ulm, Germany.

Andreas Hellmann (A)

Institut für Analytische und Bioanalytische Chemie, Universität Ulm, Ulm, Germany.

Boris Mizaikoff (B)

Institut für Analytische und Bioanalytische Chemie, Universität Ulm, Ulm, Germany.

Peter Radermacher (P)

Institut für Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätsklinikum Ulm, Helmholzstraße 8/1, 89081, Ulm, Germany.

Clair Hartmann (C)

Institut für Anästhesiologische Pathophysiologie und Verfahrensentwicklung, Universitätsklinikum Ulm, Helmholzstraße 8/1, 89081, Ulm, Germany.
Klinik für Anästhesiologie, Universitätsklinikum Ulm, Ulm, Germany.

Classifications MeSH